# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-25-000309
Filing Date
2025-03-11
Accepted
2025-03-11 16:01:35
Documents
84
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | atxs-20241231x10k.htm iXBRL | 10-K | 2353117
2 | EX-19.1 | atxs-20241231xex19d1.htm | EX-19.1 | 87484
3 | EX-21.1 | atxs-20241231xex21d1.htm | EX-21.1 | 4163
4 | EX-23.1 | atxs-20241231xex23d1.htm | EX-23.1 | 5631
5 | EX-31.1 | atxs-20241231xex31d1.htm | EX-31.1 | 9480
6 | EX-31.2 | atxs-20241231xex31d2.htm | EX-31.2 | 9486
7 | EX-32.1 | atxs-20241231xex32d1.htm | EX-32.1 | 5400
8 | EX-32.2 | atxs-20241231xex32d2.htm | EX-32.2 | 5376
9 | GRAPHIC | atxs-20241231xex19d1001.jpg | GRAPHIC | 9684
| Complete submission text file | 0001410578-25-000309.txt |  | 8509396

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | EX-101.SCH | atxs-20241231.xsd | EX-101.SCH | 48687
11 | EX-101.CAL | atxs-20241231_cal.xml | EX-101.CAL | 52226
12 | EX-101.DEF | atxs-20241231_def.xml | EX-101.DEF | 210780
13 | EX-101.LAB | atxs-20241231_lab.xml | EX-101.LAB | 482163
14 | EX-101.PRE | atxs-20241231_pre.xml | EX-101.PRE | 355637
87 | EXTRACTED XBRL INSTANCE DOCUMENT | atxs-20241231x10k_htm.xml | XML | 1239693

Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37467 | Film No.: 25727494
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)